SHOW / EPISODE

Shared Decisions, Better Care | IVIG, SCIG & What Matters to the Patient

13m | Sep 24, 2026

What happens when the “right” Ig therapy doesn’t fit the patient’s life?

Allergist-immunologist Elena Perez, MD, joins host Rachel Coletta to discuss shared decision-making, IVIG, SCIG, treatment adherence, and why understanding what matters to the patient is essential to building a sustainable treatment plan.

Through the story of a patient with X-linked agammaglobulinemia, Dr. Perez explores how treatment decisions can change over time as independence, work, travel, insurance coverage, side effects, access to care, and personal preferences change. The conversation also looks at how clinicians can incorporate meaningful shared decision-making into real-world practice—even when time is limited.


🎧 IN THIS EPISODE

✓ What shared decision-making actually looks like in clinical practice

✓ Choosing between IVIG and SCIG based on individual patient needs

✓ How lifestyle, access, insurance, and treatment burden affect decisions

✓ Recognizing barriers to treatment adherence

✓ How to discover what matters most to the patient


👤 ABOUT THE GUEST

Elena Perez, MD, is an allergist-immunologist with more than 20 years of experience caring for patients with immune disorders. She trained and taught at the Children’s Hospital of Philadelphia, served on the faculty at the University of South Florida and the University of Miami, and currently practices in Florida. She has published extensively in primary immunodeficiency and remains active in professional organizations.


🔗 EXPLORE IgNS

Clinical Standards & Guides

Membership

IgCN® and IgCP® Certification

Conferences & Education


🎙️ ABOUT NEXT QUESTION WITH IgNS

Next Question with IgNS brings together healthcare professionals, patients, researchers, and industry leaders to explore the questions and stories shaping Ig therapy, biologics, and patient care.


#IgTherapy #IVIG #SCIG #SharedDecisionMaking #IgNS

Paused
Audio Player Image
Next Question with IgNS
Loading...